NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP is investigating claims on behalf of investors of AppLovin Corporation ("AppLovin" or the "Company") (NASDAQ:APP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether AppLovin and certain of its officers and/or directors […]
NEW YORK, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Apogee Enterprises, Inc. ("Apogee" or the "Company") (NASDAQ:APOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Apogee and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Brown & Brown, Inc. ("Brown & Brown" or the "Company") (NYSE:BRO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Brown & Brown and
NEW YORK, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP is investigating claims on behalf of investors of New Era Energy & Digital, Inc. ("New Era" or the "Company") (NASDAQ:NUAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether New Era and certain
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. ("Zenas" or the "Company") (NASDAQ:ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Zenas and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP is investigating claims on behalf of investors of AST SpaceMobile, Inc. ("AST" or the "Company") (NASDAQ:ASTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether AST and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP is investigating claims on behalf of investors of PDD Holdings Inc. ("PDD" or the "Company") (NASDAQ:PDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether PDD and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ:MREO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Mereo and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Carvana Co. ("Carvana" or the "Company") (NYSE:CVNA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Carvana and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Atlassian Corporation ("Atlassian" or the "Company") (NASDAQ:TEAM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Atlassian and certain of its officers and/or directors